Professor of Vascular Surgery
Uppsala University
Consultant Vascular Surgery
Uppsala University Hospital
Uppsala, Sweden
Presenter
SESSION 29: FOOT PERFUSION EVALUATION METHODS; LOWER EXTREMITY RCTS: NEW CONCLUSIONS PRO AND CON
Presenter
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDS): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAR
Presenter
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDS): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAR
Presenter
SESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAS
Presenter
SESSION 52: PROGRESS IN ENDO AND OPEN TREATMENT TECHNIQUES FOR RUPTURED INFRARENAL AAAS, COMPLEX AAAS AND TAAAS; NEW DEVELOPMENTS IN SURVEILLANCE AND SCREENING
Presenter
SESSION 94: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT AND ENDOGRAFT INFECTIONS
Presenter
SESSION 114: AORTIC TOPICS TOO IMPORTANT TO MISS
SESSION 29: FOOT PERFUSION EVALUATION METHODS; LOWER EXTREMITY RCTS: NEW CONCLUSIONS PRO AND CON
How Can We Understand And Best Use The Diverging Results Of The BEST-CLI, BASIL 2, And BASIL 3 RCTs For The Treatment Of CTLI Patients
4:06 PM - 4:11 PM
Presenter
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDS): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAR
Endovascular (Endograft) Treatment Of Complex Aortic Diseases In Patients With CTDs: When Is It Indicated And When Is It Not: From The Results Of An International Multicenter Study Including Marfan, Vascular EDS And Loeys-Dietz Syndromes
2:18 PM - 2:23 PM
Presenter
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDS): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAR
Medical Treatment Of Patients With Vascular Ehlers Danlos Syndrome: How Does Celiprolol (A Beta Blocker) Treatment Work And How Does It Help
2:48 PM - 2:53 PM
Presenter
SESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAS
Update On Advances In Treatment Of Abdominal Compartment Syndrome Associated With Ruptured AAAs: When And How Can It Be Treated Medically And When Must The Abdomen Be Opened
1:24 PM - 1:29 PM
Presenter
SESSION 52: PROGRESS IN ENDO AND OPEN TREATMENT TECHNIQUES FOR RUPTURED INFRARENAL AAAS, COMPLEX AAAS AND TAAAS; NEW DEVELOPMENTS IN SURVEILLANCE AND SCREENING
Rapid In Situ Laser Fenestration For Endovascular Treatment Of Ruptured Complex AAAs: How To Do It With Minimal SMA And Renal Ischemia And Results
2:48 PM - 2:53 PM
Presenter
SESSION 94: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT AND ENDOGRAFT INFECTIONS
Current Concepts In Treatment Of Aortic Graft And Endograft Infections, Including EVAR, F/EVAR, TAAA And Arch Endografts: From The GRANDPA Registry
7:56 AM - 8:01 AM
Presenter
SESSION 114: AORTIC TOPICS TOO IMPORTANT TO MISS
Management Of Congenital AAAs In Infants With And Without Rupture: What Is The Best Graft And Long-Term Prognosis
10:00 AM - 10:05 AM
Power Point Presentation with Synched Audio
Power Point Presentation with Synched Audio